Selective Expansion of CD34+ Cells from Mouse Bone Marrow Cultured on LH/P MP-Coated Plates with Adequate Cytokines

Author:

Kishimoto Satoko123,Ishihara Masayuki1,Kanatani Yasuhiro4,Nambu Masaki5,Takikawa Megumi5,Sumi Yuki5,Nakamura Shingo6,Mori Yasutaka1,Hattori Hidemi1,Tanaka Yoshihiro1,Sato Toshinori3

Affiliation:

1. Research Institute, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan

2. Research Fellow of the Japan Society for the Promotion of Science, Tokyo 102-8472, Japan

3. Department of Biosciences and Informatics, School of Fundamental Science and Technology, Keio University, Yokohama, Kanagawa 223-8522, Japan

4. Department of Policy Science, National Institute of Public Health, Wako, Saitama 351-0197, Japan

5. Department of Plastic and Reconstructive Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan

6. Department of Surgery, National Defense Medical College, Tokorozawa, Saitama 359-8513, Japan

Abstract

Low-molecular-weight heparin/protamine microparticles (LH/P MPs) serve as carriers for controlled release of heparin-binding cytokines. LH/P MPs were stably coated onto plastic surfaces by drying. The purpose of this study is to evaluate a culture method for selective expansion of CD34+ cells using LH/P MPs as cytokine-binding matrix. Ficoll-purified mouse bone marrow cells (mouse FP-BMCs) containing CD34+ cells were cultured on LH/P MP-coated plates in the presence of stem cell factor (SCF), thrombopoietin (Tpo), and Flt-3 ligand (Flt-3) in hematopoietic progenitor growth medium (HPGM) supplemented with 4% heat-inactivated fetal bovine serum (FBS). After 8 days of culture, the total cell count increased 4.6-fold, and flow cytometry analyses revealed that 23.8% of the initial cells and 57.4% of the expanded cells were CD34 positive. Therefore, CD34+ cells were estimated to have increased 11.0-fold. In contrast, cultured CD34+ cells on uncoated tissue culture plates increased 5.8-fold in an identical medium.

Publisher

SAGE Publications

Subject

Biomedical Engineering,Biomaterials,Medicine (miscellaneous)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3